MedTrace Logo

Mindfulness for Central Serous Chorioretinopathy

NCT07767058 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-08-17

No results posted yet for this study

Summary

The primary goal of this clinical trial is to test whether a mindfulness-based treatment is effective at shortening the duration of, and improving the features of, central serous chorioretinopathy in adults. Researchers will compare adults with central serous chorioretinopathy who undertake an 8 week mindfulness-based treatment course, with those who do no mindfulness, to see if mindfulness improves time to disease resolution and disease features.

The secondary goal of this clinical trial is to compare adults with central serous chorioretinopathy to adults with healthy eyes across a variety of stress-related factors, and also measure the change in some of these factors, if any, caused by mindfulness.

The questions this clinical trial aims to answer are:

* is mindfulness effective at improving the clinical course of central serous chorioretinopathy?
* is a mindfulness-based treatment programme for central serous chorioretinopathy acceptable to adults with the disease?
* if effective, does mindfulness alter any stress-related psychological or biological features in adults with central serous chorioretinopathy?
* what are the stress-related psychological and biological features of adults with central serous chorioretinopathy, compared to adults with healthy eyes?

Participants will:

* Undertake daily mindfulness practices for 8 weeks and participate in fortnightly group sessions, or undertake no mindfulness
* Visit the research clinic once every month for the first six months, and then again at 12 months, for checkups and tests

Conditions

  • Central Serous Chorioretinopathy

Interventions

BEHAVIORAL

Mindfulness

The intervention is an 8 week course of daily mindfulness practices, accompanied by 6 months of fortnightly group sessions. Two introductory videos will explain about central serous chorioretinopathy, mindfulness and the links both have to stress-related factors, and outline the structure of the mindfulness course. Participants will be given a set of video and audio files that will guide them through daily mindfulness practices, for a total duration of 8 weeks. Daily practices will include body scan exercises, breathing exercises, mindful movement, mindful moments in daily life exercises, and mindfulness in response to stress exercises. Individual practices will range from 5 - 20 minutes' duration. There will also be fortnightly group mindfulness sessions, facilitated by a mindfulness coach and with an Ophthalmologist present. They will include guided mindfulness practices and free discussion time for participants to share their experience of the intervention and ask questions.

Sponsors & Collaborators

Principal Investigators

  • Timothy Jackson · King's College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2030-07-31
Completion
2030-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07767058 on ClinicalTrials.gov